2023 Q1 Form 10-K Financial Statement
#000117891323000707 Filed on February 22, 2023
Income Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
Revenue | $943.9M | $890.7M | $3.110B |
YoY Change | 44.09% | 61.38% | 58.38% |
Cost Of Revenue | $643.8M | $629.7M | $2.266B |
YoY Change | 35.21% | 60.86% | 69.77% |
Gross Profit | $300.1M | $261.0M | $844.6M |
YoY Change | 67.71% | 62.66% | 34.22% |
Gross Profit Margin | 31.8% | 29.31% | 27.16% |
Selling, General & Admin | $77.53M | $72.68M | $272.2M |
YoY Change | 25.57% | 31.83% | 35.28% |
% of Gross Profit | 25.83% | 27.84% | 32.22% |
Research & Development | $79.87M | $78.96M | $289.8M |
YoY Change | 20.38% | 22.75% | 31.95% |
% of Gross Profit | 26.61% | 30.25% | 34.31% |
Depreciation & Amortization | $13.46M | $12.36M | $40.58M |
YoY Change | 15.47% | 17.13% | 38.22% |
% of Gross Profit | 4.49% | 4.74% | 4.8% |
Operating Expenses | $156.0M | $237.8M | $678.5M |
YoY Change | 21.76% | 99.1% | 60.72% |
Operating Profit | $144.2M | $23.21M | $166.1M |
YoY Change | 183.41% | -43.43% | -19.8% |
Interest Expense | $23.67M | $56.10M | $13.54M |
YoY Change | -534.47% | -987.11% | 112.33% |
% of Operating Profit | 16.42% | 241.67% | 8.15% |
Other Income/Expense, Net | -$125.0K | $186.0K | $3.316M |
YoY Change | -116.65% | ||
Pretax Income | $167.7M | $51.12M | $177.2M |
YoY Change | 269.27% | 47.27% | -5.38% |
Income Tax | $29.33M | $30.30M | $83.38M |
% Of Pretax Income | 17.49% | 59.26% | 47.06% |
Net Earnings | $138.4M | $20.83M | $93.78M |
YoY Change | 317.77% | -49.14% | -44.57% |
Net Earnings / Revenue | 14.66% | 2.34% | 3.02% |
Basic Earnings Per Share | $2.46 | $1.70 | |
Diluted Earnings Per Share | $2.46 | $0.35 | $1.65 |
COMMON SHARES | |||
Basic Shares Outstanding | 56.15M shares | 55.89M shares | 55.09M shares |
Diluted Shares Outstanding | 59.19M shares | 58.10M shares |
Balance Sheet
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $1.139B | $1.024B | $1.024B |
YoY Change | -1.95% | 46.78% | 46.78% |
Cash & Equivalents | $727.8M | $783.1M | $783.1M |
Short-Term Investments | $410.8M | $241.1M | $241.1M |
Other Short-Term Assets | $259.6M | $241.1M | $37.82M |
YoY Change | 35.47% | 36.21% | -78.63% |
Inventory | $874.2M | $729.2M | $729.2M |
Prepaid Expenses | $9.233M | ||
Receivables | $969.5M | $905.1M | $905.1M |
Other Receivables | $0.00 | $0.00 | $203.3M |
Total Short-Term Assets | $3.242B | $2.900B | $2.900B |
YoY Change | 31.67% | 69.44% | 69.44% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $625.8M | $544.0M | $606.7M |
YoY Change | 17.36% | 32.55% | 32.61% |
Goodwill | $29.93M | $31.19M | |
YoY Change | -75.94% | ||
Intangibles | $17.93M | $19.93M | |
YoY Change | -66.14% | ||
Long-Term Investments | $509.1M | $645.5M | $645.5M |
YoY Change | 13.22% | 33.86% | 33.86% |
Other Assets | $71.52M | $18.81M | $62.96M |
YoY Change | 30.54% | -44.45% | 2.49% |
Total Long-Term Assets | $1.254B | $1.366B | $1.366B |
YoY Change | 2.77% | 14.85% | 14.85% |
TOTAL ASSETS | |||
Total Short-Term Assets | $3.242B | $2.900B | $2.900B |
Total Long-Term Assets | $1.254B | $1.366B | $1.366B |
Total Assets | $4.496B | $4.266B | $4.266B |
YoY Change | 22.09% | 47.05% | 47.05% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $408.5M | $459.8M | $459.8M |
YoY Change | 69.07% | 82.42% | 82.42% |
Accrued Expenses | $334.7M | $117.6M | $291.5M |
YoY Change | 52.67% | 105.81% | 58.53% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $3.263M | ||
YoY Change | |||
Total Short-Term Liabilities | $900.0M | $889.7M | $889.7M |
YoY Change | 58.25% | 69.41% | 69.41% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $668.9M | $669.8M | $669.8M |
YoY Change | -1.0% | 1.18% | 1.18% |
Other Long-Term Liabilities | $576.7M | $15.76M | $530.0M |
YoY Change | 34.75% | -19.37% | 31.3% |
Total Long-Term Liabilities | $1.246B | $1.200B | $1.200B |
YoY Change | 12.86% | 12.59% | 12.59% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $900.0M | $889.7M | $889.7M |
Total Long-Term Liabilities | $1.246B | $1.200B | $1.200B |
Total Liabilities | $2.146B | $2.090B | $2.090B |
YoY Change | 28.3% | 31.34% | 31.34% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $882.2M | $743.8M | |
YoY Change | 14.43% | ||
Common Stock | $6.000K | $6.000K | |
YoY Change | 20.0% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $2.351B | $2.176B | $2.176B |
YoY Change | |||
Total Liabilities & Shareholders Equity | $4.496B | $4.266B | $4.266B |
YoY Change | 22.09% | 47.05% | 47.05% |
Cashflow Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $138.4M | $20.83M | $93.78M |
YoY Change | 317.77% | -49.14% | -44.57% |
Depreciation, Depletion And Amortization | $13.46M | $12.36M | $40.58M |
YoY Change | 15.47% | 17.13% | 38.22% |
Cash From Operating Activities | $7.923M | $111.3M | $31.28M |
YoY Change | -104.86% | 24.25% | -85.39% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $38.34M | $44.26M | $169.3M |
YoY Change | -188.72% | -184.91% | 13.46% |
Acquisitions | $0.00 | ||
YoY Change | |||
Other Investing Activities | -$3.440M | $7.726M | -$4.138M |
YoY Change | -112.25% | -122.64% | -304.65% |
Cash From Investing Activities | -$67.78M | -$36.53M | -$417.0M |
YoY Change | 347.87% | -57.65% | -13.87% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -$5.222M | 7.472M | $654.6M |
YoY Change | -100.8% | 75.65% | -4412.87% |
NET CHANGE | |||
Cash From Operating Activities | $7.923M | 111.3M | $31.28M |
Cash From Investing Activities | -$67.78M | -36.53M | -$417.0M |
Cash From Financing Activities | -$5.222M | 7.472M | $654.6M |
Net Change In Cash | -$65.08M | 82.24M | $268.8M |
YoY Change | -113.72% | 985.13% | -194.25% |
FREE CASH FLOW | |||
Cash From Operating Activities | $7.923M | $111.3M | $31.28M |
Capital Expenditures | $38.34M | $44.26M | $169.3M |
Free Cash Flow | -$30.42M | $67.04M | -$138.1M |
YoY Change | -74.61% | -52.68% | -312.79% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
-116538000 | usd |
CY2022 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
9096000 | usd |
CY2021 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
10176000 | usd |
CY2020 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
9479000 | usd |
CY2022 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
2916000 | usd |
CY2021 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
2903000 | usd |
CY2020 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
3185000 | usd |
CY2022 | sedg |
Amortization Of Marketable Securities Premium Accretion
AmortizationOfMarketableSecuritiesPremiumAccretion
|
9310000 | usd |
CY2021 | sedg |
Amortization Of Marketable Securities Premium Accretion
AmortizationOfMarketableSecuritiesPremiumAccretion
|
9462000 | usd |
CY2020 | sedg |
Amortization Of Marketable Securities Premium Accretion
AmortizationOfMarketableSecuritiesPremiumAccretion
|
1168000 | usd |
CY2022 | sedg |
Exchange Rate Fluctuations Net And Other Items
ExchangeRateFluctuationsNetAndOtherItems
|
10052000 | usd |
CY2021 | sedg |
Exchange Rate Fluctuations Net And Other Items
ExchangeRateFluctuationsNetAndOtherItems
|
20697000 | usd |
CY2020 | sedg |
Exchange Rate Fluctuations Net And Other Items
ExchangeRateFluctuationsNetAndOtherItems
|
3860000 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
98673000 | usd |
CY2021 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
3344000 | usd |
CY2020 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
11630000 | usd |
CY2021Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
530089000 | usd |
CY2020Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
827146000 | usd |
CY2019Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
223901000 | usd |
CY2022 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
4030000 | usd |
CY2021 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
6486000 | usd |
CY2020 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
16671000 | usd |
CY2022 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | usd |
CY2021 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
0 | usd |
CY2020 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
617869000 | usd |
CY2022 | us-gaap |
Proceeds From Bank Debt
ProceedsFromBankDebt
|
0 | usd |
CY2020 | us-gaap |
Proceeds From Bank Debt
ProceedsFromBankDebt
|
16944000 | usd |
CY2020Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
827146000 | usd |
CY2021 | us-gaap |
Severance Costs1
SeveranceCosts1
|
14231000 | usd |
CY2020 | us-gaap |
Severance Costs1
SeveranceCosts1
|
10598000 | usd |
CY2022Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
503257000 | usd |
CY2021Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
247386000 | usd |
CY2022Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
23407000 | usd |
CY2021Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
13863000 | usd |
CY2022Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
202537000 | usd |
CY2021Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
118894000 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
729201000 | usd |
CY2021Q4 | sedg |
Government Authorities Receivable Current
GovernmentAuthoritiesReceivableCurrent
|
63440000 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
|
4083000 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
16330000 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
|
3298000 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
14746000 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
|
3369000 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
7338000 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
|
3539000 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
4246000 | usd |
CY2022Q4 | us-gaap |
Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
|
3539000 | usd |
CY2022Q4 | sedg |
Provision For Legal Claims
ProvisionForLegalClaims
|
43000 | usd |
CY2021Q4 | sedg |
Provision For Legal Claims
ProvisionForLegalClaims
|
11622000 | usd |
CY2022Q4 | sedg |
Deferred Tax Assets Net1
DeferredTaxAssetsNet1
|
44153000 | usd |
CY2021Q4 | sedg |
Deferred Tax Assets Net1
DeferredTaxAssetsNet1
|
27572000 | usd |
CY2022 | sedg |
Effective Income Tax Rate Reconciliation Disallowable And Allowable Deductions
EffectiveIncomeTaxRateReconciliationDisallowableAndAllowableDeductions
|
0.132 | pure |
CY2021 | sedg |
Effective Income Tax Rate Reconciliation Disallowable And Allowable Deductions
EffectiveIncomeTaxRateReconciliationDisallowableAndAllowableDeductions
|
0.02 | pure |
CY2022 | sedg |
Expenses Income Net Related To Hedging Transactions
ExpensesIncomeNetRelatedToHedgingTransactions
|
-4716000 | usd |
CY2021 | sedg |
Expenses Income Net Related To Hedging Transactions
ExpensesIncomeNetRelatedToHedgingTransactions
|
-9417000 | usd |
CY2021 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
-1350000 | usd |
CY2020 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
3429000 | usd |
CY2022 | us-gaap |
Other Income
OtherIncome
|
7719000 | usd |
CY2021 | us-gaap |
Other Income
OtherIncome
|
0 | usd |
CY2020 | us-gaap |
Other Income
OtherIncome
|
0 | usd |
CY2020 | sedg |
Equity Component Of Convertible Senior Notes Net
EquityComponentOfConvertibleSeniorNotesNet
|
36336000 | usd |
CY2021 | sedg |
Cumulative Effect Of Adopting Asc606
CumulativeEffectOfAdoptingAsc606
|
-33452000 | usd |
CY2022 | sedg |
Underwriters Discounts And Commissions
UnderwritersDiscountsAndCommissions
|
27140000 | usd |
CY2022 | sedg |
Offering Costs
OfferingCosts
|
834000 | usd |
CY2022 | us-gaap |
Depreciation
Depreciation
|
40580000 | usd |
CY2021 | us-gaap |
Depreciation
Depreciation
|
29359000 | usd |
CY2020 | us-gaap |
Depreciation
Depreciation
|
22355000 | usd |
CY2022 | sedg |
Gain From Sale Of Privately Held Company
GainFromSaleOfPrivatelyHeldCompany
|
7719000 | usd |
CY2021 | sedg |
Gain From Sale Of Privately Held Company
GainFromSaleOfPrivatelyHeldCompany
|
0 | usd |
CY2020 | sedg |
Gain From Sale Of Privately Held Company
GainFromSaleOfPrivatelyHeldCompany
|
0 | usd |
CY2022 | sedg |
Proceeds From Sale Of A Privately Held Company
ProceedsFromSaleOfAPrivatelyHeldCompany
|
24362000 | usd |
CY2021 | sedg |
Proceeds From Sale Of A Privately Held Company
ProceedsFromSaleOfAPrivatelyHeldCompany
|
0 | usd |
CY2020 | sedg |
Proceeds From Sale Of A Privately Held Company
ProceedsFromSaleOfAPrivatelyHeldCompany
|
0 | usd |
CY2022 | sedg |
Withdrawal From Investment Restricted Bank
WithdrawalFromInvestmentRestrictedBank
|
242000 | usd |
CY2021 | sedg |
Withdrawal From Investment Restricted Bank
WithdrawalFromInvestmentRestrictedBank
|
-798000 | usd |
CY2020 | sedg |
Withdrawal From Investment Restricted Bank
WithdrawalFromInvestmentRestrictedBank
|
-25267000 | usd |
CY2021 | us-gaap |
Proceeds From Bank Debt
ProceedsFromBankDebt
|
0 | usd |
CY2022 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-15824000 | usd |
CY2021 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-11797000 | usd |
CY2020 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-23257000 | usd |
CY2022Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
783112000 | usd |
CY2021Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
530089000 | usd |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:12pt;text-indent:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.<span style="padding-left:8.6pt">Use of estimates:</span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes. The duration, scope and effects of the ongoing Covid-19 pandemic and the conflict in Ukraine, government and other third-party responses to it, and the related macroeconomic effects, including to the Company’s business and the business of the Company’s suppliers and customers are uncertain, rapidly changing and difficult to predict. As a result, the Company’s accounting estimates and assumptions may change over time in response to this evolving situation. Such changes could result in future impairments of goodwill, intangibles, long-lived assets, inventories, incremental credit losses on receivables and available-for-sale marketable debt securities, or an increase in the Company’s insurance liabilities as of the time of a relevant measurement event.</span></span></div> | |
CY2022 | us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
103000 | usd |
CY2022Q4 | sedg |
Reduction Of Fixed Assets
ReductionOfFixedAssets
|
7359000 | usd |
CY2022 | us-gaap |
Derivatives Methods Of Accounting Hedging Derivatives
DerivativesMethodsOfAccountingHedgingDerivatives
|
<div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;text-indent:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">t.<span style="padding-left:8.6pt">Derivatives and Hedging:</span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for derivatives and hedging based on ASC 815 (“Derivatives and Hedging”). ASC 815 requires the Company to recognize all derivatives on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">To protect against the increase in value of forecasted foreign currency cash flows resulting from salary denominated in the Israeli currency, the New Israeli Shekels (“NIS”), during the year ended December 31, 2022, the Company instituted a foreign currency cash flow hedging program whereby portions of the anticipated payroll denominated in NIS for a period of one to nine months with hedging contracts.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:11pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accordingly, when the dollar strengthens against the NIS, the decline in present value of future foreign currency expenses is offset by losses in the fair value of the hedging contracts. Conversely, when the dollar weakens, the increase in the present value of future foreign currency cash flows is offset by gains in the fair value of the hedging contracts. These hedging contracts are designated as cash flow hedges, as defined by ASC 815 and are all effective hedges.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0pt;padding-left:0pt;margin-bottom:10pt"> <div/> <p style="margin:0pt"><span style="font-size:10pt">The Company al</span><span style="font-size:10pt">so entered into derivative instrument arrangements to hedge the Company’s exposure to currencies other than the U.S. dollar. These derivative instruments are not designated as cash flow hedges, as defined by ASC 815, and therefore all gains and losses, resulting from fair value remeasurement, were recorded immediately in the statement of income, as a financial income (expense), net..</span></p> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:10pt"> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies cash flows related to its hedging as operating activities in its consolidated statement of cash flows.</span></span></p> </div> </div> | |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div> <div> <div> <div> <div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:12pt;text-indent:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">aa.<span style="padding-left:8.6pt">Concentrations of credit risks:</span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term bank deposits, restricted bank deposits, marketable securities, trade receivables, derivative instruments and other accounts receivable.</span></span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Cash and cash equivalents, short-term bank deposits and restricted bank deposits are mainly invested in major banks in the U.S., Israel, Germany and Korea. Management believes that the financial institutions that hold the Company’s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments.</span></span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span style="color:black">The Company's debt marketable securities include investments in highly-rated corporate debentures (located mainly in U.S., Canada, France, UK, Cayman Islands and other countries) and governmental bonds</span></span></span><span><span>. The financial institutions that hold the Company's debt marketable securities are major financial institutions located in the United States. The Company believes its debt marketable securities portfolio is a diverse portfolio of highly-rated securities and the Company's investment policy limits the amount the Company may invest in an issuer (see Note 2g.).</span></span></span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>The trade receivables of the Company derive from sales to customers located primarily in the United States and Europe.</span></span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company performs ongoing credit evaluations of its customers for the purpose of determining the appropriate allowance for credit losses (see Note 2i.). The Company generally does not require collaterals, however, in certain circumstances, the Company may require letters of credit, other collateral, or additional guarantees. From time to time, the Company may purchase trade credit insurance.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"> <div/> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0px;padding-left:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company had one major customer (customers with attributable revenues that represents more than 10% of total revenues) for the year ended December 31, 2022, two major customers for the year ended December 31, 2021, and one major customer for the year ended December 31, 2020 that accounted for approximately 18.5%, 30.9%% and 14.8% of the Company’s consolidated revenues, respectively. All of the revenues from these customers were generated in the solar segment.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company had three major customers (customer with a balance that represents more than 10% of total trade receivables, net) as of December 31, 2022 and two major customers for the year ended December 31, 2021 that accounted in the aggregate for approximately 42.2% and 39.3%, of the Company’s consolidated trade receivables, net, respectively.</span></span></p> </div> </div> </div> </div> </div> </div> | |
CY2022 | sedg |
Concentrations Of Supply Risks
ConcentrationsOfSupplyRisks
|
<div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:12pt;text-indent:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ab.<span style="padding-left:8.6pt">Concentrations of supply risks:</span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company depends on two contract manufacturers and several limited or single source component suppliers, including, Samsung SDI, that provides lithium-ion battery cells required for the Company's residential storage solution. Reliance on these vendors makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields, and costs. </span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2022 and 2021, two contract manufacturers collectively accounted for 34.3% and 27.9% of the Company’s total trade payables, net, respectively.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:11pt;text-indent:0px;margin-bottom:0pt;margin-left:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In the second quarter of 2022, the Company announced the opening of “Sella 2”, a two gigawatt-hour (GWh) Li-Ion battery cell manufacturing facility located in South Korea. Sella 2 is in the ramp-up phase, that is expected to continue throughout 2023. Sella 2 is the Company's second owned manufacturing facility following the establishment of Sella 1 in 2020. Sella 1 is the Company's manufacturing facility in the North of Israel that produces power optimizers and inverters for the Company's solar activities.</span></span></div> </div> | |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
380143000 | usd |
CY2022Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
|
3285000 | usd |
CY2020Q4 | us-gaap |
Goodwill
Goodwill
|
140479000 | usd |
CY2022 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
-8336000 | usd |
CY2022Q4 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
90104000 | usd |
CY2022Q4 | us-gaap |
Derivative Assets
DerivativeAssets
|
0 | usd |
CY2021Q4 | us-gaap |
Derivative Assets
DerivativeAssets
|
4009000 | usd |
CY2022Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
1874000 | usd |
CY2021Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
169000 | usd |
CY2022Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
214112000 | usd |
CY2021Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
109379000 | usd |
CY2022 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
2916000 | usd |
CY2021 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
2903000 | usd |
CY2020 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
3185000 | usd |
CY2022Q4 | sedg |
Other Noncurrent Liabilities
OtherNoncurrentLiabilities
|
2078000 | usd |
CY2021Q4 | sedg |
Other Noncurrent Liabilities
OtherNoncurrentLiabilities
|
3805000 | usd |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
10000000 | shares |
CY2022 | sedg |
Capitalized Stock Based Compensation
CapitalizedStockBasedCompensation
|
380000 | usd |
CY2020 | sedg |
Other Comprehensive Income Loss Reclassifications Tax On Revaluation
OtherComprehensiveIncomeLossReclassificationsTaxOnRevaluation
|
-204000 | usd |
CY2021 | us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
-2427000 | usd |
CY2022 | us-gaap |
Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
|
-90104000 | usd |
CY2021 | us-gaap |
Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
|
0 | usd |
CY2020 | us-gaap |
Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
|
0 | usd |
CY2022 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
-29037000 | usd |
CY2021 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
-2209000 | usd |
CY2020 | us-gaap |
Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
|
-1471000 | usd |
CY2022 | us-gaap |
Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
-2603000 | usd |
CY2021 | us-gaap |
Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
0 | usd |
CY2020 | us-gaap |
Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
|
0 | usd |
CY2022 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
-116538000 | usd |
CY2021 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
-1350000 | usd |
CY2020 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
3429000 | usd |
CY2020 | sedg |
Effective Income Tax Rate Reconciliation Disallowable And Allowable Deductions
EffectiveIncomeTaxRateReconciliationDisallowableAndAllowableDeductions
|
-0.026 | pure |
CY2022 | sedg |
Effective Income Tax Rate Reconciliation Annual Revenue
EffectiveIncomeTaxRateReconciliationAnnualRevenue
|
10000000000 | ils |
CY2020 | sedg |
Expenses Income Net Related To Hedging Transactions
ExpensesIncomeNetRelatedToHedgingTransactions
|
4013000 | usd |
CY2022 | sedg |
Disposal Of Assets Related To Critical Power
DisposalOfAssetsRelatedToCriticalPower
|
-4314000 | usd |
CY2021 | sedg |
Disposal Of Assets Related To Critical Power
DisposalOfAssetsRelatedToCriticalPower
|
0 | usd |
CY2020 | sedg |
Disposal Of Assets Related To Critical Power
DisposalOfAssetsRelatedToCriticalPower
|
0 | usd |